Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Name: Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Published: 2010
License: Public Domain

Sunovion Respiratory Development Inc. · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

chronic-obstructive-pulmonary-disease copd

chronic obstructive pulmonary disease, copd, emphysema, chronic bronchitis, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Related documents